Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Susceptibility

Implications of the “EUCAST trailing” phenomenon in C. tropicalis for the in vivo susceptibility in invertebrate and murine models.

KMT Astvad, D Sanglard, E Delarze, RK Hare, MC Arendrup
KMT Astvad
aUnit of Mycology, Statens Serum Institut, Artillerivej 5, DK-2300 Kbh S, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D Sanglard
bInstitute of Microbiology, University of Lausanne and University Hospital Center, Rue du Bugnon 48, CH-1011 Lausanne, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for D Sanglard
E Delarze
bInstitute of Microbiology, University of Lausanne and University Hospital Center, Rue du Bugnon 48, CH-1011 Lausanne, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RK Hare
aUnit of Mycology, Statens Serum Institut, Artillerivej 5, DK-2300 Kbh S, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for RK Hare
MC Arendrup
aUnit of Mycology, Statens Serum Institut, Artillerivej 5, DK-2300 Kbh S, Denmark
cDepartment of Clinical Microbiology, Rigshospitalet, Blegdamsvej 9, DK-2100 Kbh Ø, Denmark
dDepartment of Clinical Medicine, University of Copenhagen, Blegdamsvej 3B, DK-2200 KBH N, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for MC Arendrup
  • For correspondence: maca@ssi.dk
DOI: 10.1128/AAC.01624-18
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Candida tropicalis isolates often display reduced but persistent growth (trailing) over a broad fluconazole concentration range during EUCAST susceptibility testing. Whereas weak trailing (<25% of the positive growth control) is common and found not to impair fluconazole efficacy, we investigated if more pronounced trailing impacted treatment efficacy.

Fluconazole efficacy against two weakly (≤25% growth), two moderately (26-50% growth), one resistant heavily (>70% growth) trailing, and one resistant (100% growth) isolates was investigated in vitro and in vivo (a Galleria mellonella survival model and two non-lethal murine models). CDR1 expression levels and ERG11 sequences were characterised.

Survival in fluconazole-treated G. mellonella was inversely correlated with the degree of trailing (71% to 9% survival in treatment groups). In mice, resistant and heavily trailing isolates responded poorly to fluconazole treatment. The CDR1 expression was significantly higher in trailing and resistant compared to wild-type isolates (1.4-fold to 10-fold higher). All isolates exhibited ERG11 wild-type alleles.

Heavily trailing isolates were less responsive to fluconazole in all in vivo models indicating an impact on fluconazole efficacy. CDR1 upregulation may have contributed to the observed differences. Moderately trailing isolates responded less well to fluconazole in larvae only. This confirms clinical data suggesting fluconazole efficacy against infections with such isolates in less severely ill patients and supports the current 50% growth endpoint for susceptibility testing. However, it is still unclear if the gradual loss of efficacy observed for moderately trailing isolates in the larvae model may be a reason for concern in selected vulnerable patient populations.

  • Copyright © 2018 American Society for Microbiology.

All Rights Reserved.

Next
Back to top
Download PDF
Citation Tools
Implications of the “EUCAST trailing” phenomenon in C. tropicalis for the in vivo susceptibility in invertebrate and murine models.
KMT Astvad, D Sanglard, E Delarze, RK Hare, MC Arendrup
Antimicrobial Agents and Chemotherapy Sep 2018, AAC.01624-18; DOI: 10.1128/AAC.01624-18

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Implications of the “EUCAST trailing” phenomenon in C. tropicalis for the in vivo susceptibility in invertebrate and murine models.
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Implications of the “EUCAST trailing” phenomenon in C. tropicalis for the in vivo susceptibility in invertebrate and murine models.
KMT Astvad, D Sanglard, E Delarze, RK Hare, MC Arendrup
Antimicrobial Agents and Chemotherapy Sep 2018, AAC.01624-18; DOI: 10.1128/AAC.01624-18
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596